The Lyme IgM Line Blot Interpretation (Interp.) marker is a diagnostic test marker used to assess the presence of specific antibodies called IgM antibodies in a patient's blood.
The IgM Line Blot Interp. marker helps in the diagnosis of Lyme disease by detecting IgM antibodies produced by the immune system in response to an infection with the bacterium Borrelia burgdorferi, which is the causative agent of Lyme disease. IgM antibodies are typically produced during the early stages of infection, usually within a few weeks after exposure to the bacteria.
A positive result for the IgM Line Blot Interp. marker suggests the presence of IgM antibodies against Borrelia burgdorferi, indicating a recent or active infection with Lyme disease. On the other hand, a negative result means that no IgM antibodies specific to Lyme disease were detected, suggesting the absence of an active or recent infection.
It's important to note that the interpretation of this marker should be done by a healthcare provider in conjunction with other clinical information and tests to make an accurate diagnosis of Lyme disease.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.